Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nanoform Finland's book value per share for the quarter that ended in Mar. 2026 was €0.46.
During the past 12 months, Nanoform Finland's average Book Value Per Share Growth Rate was -27.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -23.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -13.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Nanoform Finland was 215.00% per year. The lowest was -23.50% per year. And the median was 52.10% per year.
Nanoform Finland's current price is €0.896. Its book value per share for the quarter that ended in Mar. 2026 was €0.46. Hence, today's PB Ratio of Nanoform Finland is 1.93.
During the past 10 years, the highest P/B Ratio of Nanoform Finland was 81.82. The lowest was 0.91. And the median was 2.37.
Nanoform Finland (FRA:4YL) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Nanoform Finland Book Value per Share Related Terms
Nanoform Finland Book Value per Share Historical Data
* Premium members only.
The historical data trend for Nanoform Finland's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4YL vs VRTX, REGN, RVMD: Book Value per Share Comparison
For the Biotechnology subindustry, Nanoform Finland's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanoform Finland PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanoform Finland's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nanoform Finland's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanoform Finland (FRA:4YL) has a Book Value per Share of €0.46 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Nanoform Finland and its competitors.
Is Nanoform Finland's Book Value per Share too high?
Nanoform Finland's current Book Value per Share is €0.46. Overall, Nanoform Finland has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanoform Finland's Book Value per Share compare to VRTX and REGN?
Nanoform Finland's Book Value per Share of €0.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Nanoform Finland and its competitors. Nanoform Finland's current Book Value per Share is €0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoform Finland stock overvalued right now?
Based on GuruFocus' analysis, Nanoform Finland (FRA:4YL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.72, compared to a current price of €0.90 — trading 47.9% below its estimated fair value. The current Book Value per Share is €0.46. Nanoform Finland's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Nanoform Finland (FRA:4YL), the current Book Value per Share is €0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanoform Finland (FRA:4YL) Overvalued in 2026?
Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued.
The current stock price of €0.90 is trading 47.9% below its estimated GF Value™ of €1.72.
GuruFocus considers Nanoform Finland to be Possible Value Trap.
Key valuation signals for FRA:4YL:
Book Value per Share: €0.46
GF Value™: €1.72 vs. price of €0.90 (47.9% below fair value)
No single metric tells the full story. See the FRA:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
63GF Score
Get the complete analysis for FRA:4YL
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4YL has been successfully added to your 
